Confidential: Quality Improvement Material Reducing Clotting Events for Post-Surgical Orthopedic Patients Loyola Anticoagulation Clinic Spring 2009.

Slides:



Advertisements
Similar presentations
Utilizing the Electronic Medical Record to Reduce Inappropriate Medication Use Alan White, PhD – Abt Associates Valerie Weber, MD – Geisinger Health System.
Advertisements

VTE Prophylaxis in the Hospitalized Patient: Importance and Strategies for Improved Compliance Andrew H. Dombro, M.D. Instructor of Medicine Division of.
Optimizing Venous Thromboembolism Prophylaxis using Physician Order Entry: Johns Hopkins Hospital Experience Michael B. Streiff, MD Associate Professor.
Surgical Care Improvement Project - Pharmacy Process Improvement (Software) Mark Wong, Pharm.D., BCPS 1,2,3 ; George Melnik, Pharm.D., BCPS, 1,2 South.
The PERC Rule. The paper Kline et al Journal of Thrombosis and Haemostasis 2008 Prospective Multicenter Evaluation of the Pulmonary Embolism Rule Out.
Post oral surgery bleeding for adult patients receiving antithrombotic therapy.
Venous Thromboembolism Prevention August Venous Thromboembloism Prevention 2 Expected Practice  Assess all patients upon admission to the ICU for.
Venous thromboembolism –
Venous Thromboembolism (VTE) Prophylaxis Policy Mary-Anne Davies Patient Safety Specialist Accreditation Coordinator.
Deep Vein Thrombosis (DVT)
Best Practices in Meeting NPSG 3E-Anticoagulation Requirements MaryAnne Cronin, PharmD Assistant Director of Pharmacy Glen Cove Hospital.
VTE Prophylaxis Alert to providers and nursing Go live June 24, 2014.
 When untreated, general postsurgical patients risk for Deep Venous Thrombosis (DVT) is 19%-25% (Buckner, et al., 2013).  Post surgical orthopedic patients.
DPT 732 SPRING 2009 S. SCHERER Deep Vein Thrombosis.
LIFEBLOOD THE Thrombosis CHARITY Venous thromboembolism – Treatment and secondary prevention Ulcus cruris Chronic PE PE DVT Post-thrombotic syndrome Death.
WHAT YOU NEED TO KNOW ABOUT BLOOD CLOTS VTE Venous Thromboembolism Toolkit for Health Professionals.
Supervisor: Vs 余垣斌 Presenter: CR 周益聖. INTRODUCTION.
Postoperative venous thromboembolic disease prevention in the neurosurgery population Ahmad Khaldi, M.D. 1 Michael Wall, PharmD 2 T.C. Origitano, M.D.,
4-06 CHANGE IS GOOD: THE BASAL BOLUS INSULIN CONCEPT Management of Hyperglycemia in the Adult Hospitalized Patient TEAM MEMBERS: Physicians: Maryann Emanuele,
Venous Thromboembolism (VTE) Southern New Hampshire Medical Center Lynda Pittenger, RN, CPHQ Kathy Helberg, BSN,RN, CPHQ.
Preventing Surgical Complications Prevent Harm from High Alert Medication- Anticoagulants in Primary Care Insert Date here Presenter:
Stop the Clot ™ David Henry and Tom Hogan Cardiovascular and Renal Drugs Advisory Committee U.S. Food and Drug Administration Adelphi,
Clinical Pharmacy Part 2
The Role of Thromboprophylaxis in Elective Spinal Surgery The Role of Thromboprophylaxis in Elective Spinal Surgery VA Elwell, N Koo Ng, D Horner & D Peterson.
Surgical Care Improvement Project Prevention of Post-operative Venous Thromboembolism Team Membership Department of Surgery, Nursing, General Medicine,
Rivaroxaban for Prevention of Venous Thromboembolism After Total Knee Arthroplasty: Impact on Healthcare Costs Based on the RECORD3 Study Kwong L, Lees.
Confidential: Quality Improvement Material The Suicide Risk Assessment in the Psychiatric Population Team Members Mary Kenny, RN MS Lisa Beck, LCSW Lisa.
DVT Prevention and Anticoagulant Management
VTE prevention and anticoagulation practice VTE prevention and anticoagulation practice Mr A McSorley Lead Thrombosis Nurse RCHT.
ALI R. RAHIMI, BOBBY WRIGHTS, MD, HOSSEIN AKHONDI, MD & CHRISTIAN M. RICHARD, MSC Clinical Correlation Between Effective Anticoagulants & Risk of Stroke:
Venous Thromboembolism Prophylaxis for Medical Inpatients Heather Hofmann, rev. 4/18/14 DSR2 Mini Lecture.
Jomo Osborne Lung-2015 Baltimore, USA July , 2015.
Surgical Care Improvement Project Prevention of Post-operative Venous Thromboembolism Team Membership Department of Surgery, Nursing, General Medicine,
Preventing Surgical Infections Through Effective Perioperative Antibiotic Administration Project Team Members: Anesthesia Infectious Disease Pharmacy Surgical.
Risk assessment for VTE Dr Roopen Arya King’s College Hospital.
Higher Incidence of Venous Thromboembolism (VTE) in the Outpatient versus Inpatient Setting Among Patients with Cancer in the United States Khorana A et.
Mandatory Training: VTE prevention and anticoagulation practice Mandatory Training: VTE prevention and anticoagulation practice Mr A McSorley Lead Thrombosis.
Surgical Care Improvement Project Prevention of Post-operative Venous Thromboembolism Team Membership Department of Surgery, Nursing, Pharmacy, CCE Confidential:
Quality and Patient Safety Council May 27, 2014 Presented By Susan M. Blackhurst BS, RN & Eric Jean BSN, RN, CCRN.
 Deep Vein Thrombosis Josh Vrona, Hunter Dolan, Erin McCann.
Glaucoma Care Project Team Members: Geoffrey T. Emerick, M.D. Erin Herlihy, B.S. Marilyn Hauser, M.B.A. Dianna Greening, R.N. Walter M. Jay, M.D Opportunity.
PRESENTING AUTHOR HAS NO RELATIONSHIPS TO DISCLOSE
Oral Rivaroxaban Compared with Subcutaneous Enoxaparin for Extended Thromboprophylaxis After Total Hip Arthroplasty: The RECORD1 Trial Eriksson BI, Borris.
Antithrombotic Therapy for VTE: CHEST Guidelines 2016
Maile Parker, MSIV University of Washington School of Medicine Sept. 27, 2012 Venous Thromboembolism Prophylaxis in Pediatric Patients With Central Venous.
Antithrombotic and Thrombolytic Therapy for Valvular Disease Copyright: American College of Chest Physicians 2012 © Antithrombotic Therapy and Prevention.
Venous Thromboembolic (VTE) Prophylaxis in Pediatric Trauma Patients Bowe.
Treatment and Prevention of Heparin- Induced Thrombocytopenia Copyright: American College of Chest Physicians 2012 © Antithrombotic Therapy and Prevention.
Conclusions Results Methods Background Venous thrombo-embolism in patients undergoing neo- adjuvant chemotherapy and surgery for oesophago-gastric cancer.
Prevention of Venous Thromboembolism in Orthopedic Surgery Patients Copyright: American College of Chest Physicians 2012 © Antithrombotic Therapy.
Pharmacy Health Information Technology Collaborative Presenter: Shelly Spiro RPh, FASCP Pharmacy HIT Collaborative, Executive Director.
Antithrombotic and Thrombolytic Therapy for Valvular Disease Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest.
Dr. Lesbia Adalgisa Rodriguez PGY3-Cook County Loyola Family Medicine Residency Program Venous Thromboembolism Prophylaxis in the Inpatient Setting.
Pain Control in the Laboring Patient Dr John Gianopoulos MD Dr Ku-mie Kim MD Sandra Swanson RN MSOD Maureen Davey RNC Denise Goray RN BSN.
Response to An Initial Dose of Warfarin in Thai Patients Undergoing Long-Term Anticoagulant Therapy Weerayuth Saelim R.Ph. 2 nd year Pharmacy resident.
Making Surgery Safer: Preventing Post Operative Myocardial Infarction Departments: Anesthesia, Cardiology, General Surgery, Orthopaedics, Primary Care,
CRT 2012 Venous Disease.
The VERITY Steering Committee
Venous Thromboembolism Prophylaxis (VTE)
Effect of a Health Coach on A1c Levels
UNDERSTANDING YOUR RISK FOR DEVELOPING BLOOD CLOTS (VTE) IN CANCER
Ortho Warfarin Dosing Protocol
UNDERSTANDING YOUR RISK FOR DEVELOPING BLOOD CLOTS (VTE) IN CANCER
Prevention of Venous Thromboembolism in Orthopedic Surgery Patients
Aug, 2016.
Making Surgery Safer: Preventing Post Operative Myocardial Infarctions
Owen N. Johnson, MD, David L
Extraordinary Cases of VTE Prevention in Patients With Cancer
Patient engagement with digital therapeutic leads to reduction of A1C and costs in T2DM patients: Cost savings are correlated to both A1C drops as well.
Presentation transcript:

Confidential: Quality Improvement Material Reducing Clotting Events for Post-Surgical Orthopedic Patients Loyola Anticoagulation Clinic Spring 2009

Confidential: Quality Improvement Material Team Members Michael Grant, MA Anita Calistro, RN, MSN Peggy Thueson RN, BSN Brian Ing, MD Special Thanks To: Penny Bleffer-Riding and Mike Wall from CCE Joan White, RN, MS Robert Schiff, MD

Confidential: Quality Improvement Material Background Orthopedic surgery can place an otherwise healthy person at risk of having a Venous Thromboembolic Event (VTE). VTEs, such as Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), can occur post-surgically in this population even when the patient has no previous history of cardiovascular disease. Anticoagulants are administered post- surgically to mitigate the risk of clot formation.

Confidential: Quality Improvement Material Project Aim Statement The aim of the project was to reduce the incidents of VTE in post-surgical orthopedic patients through an increased International Normalized Ratio (INR) range, derived from The American College of Chest Physicians’ (CHEST) guidelines on antithrombotic therapy 1. The aim of the project was to reduce the incidents of VTE in post-surgical orthopedic patients through an increased International Normalized Ratio (INR) range, derived from The American College of Chest Physicians’ (CHEST) guidelines on antithrombotic therapy 1. The measurement goal for this project was to reduce the number of clotting events for the patient population actively taking oral anticoagulants while enrolled in the LUHS Anticoagulation clinic, with the primary diagnosis code of (post-surgical orthopedic prophylaxis). The measurement goal for this project was to reduce the number of clotting events for the patient population actively taking oral anticoagulants while enrolled in the LUHS Anticoagulation clinic, with the primary diagnosis code of (post-surgical orthopedic prophylaxis). 1 Geerts, WH, Bergqvist,, D Pineo, GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Practice Guidelines (8th Edition). Chest 2008; 133:381s.

Confidential: Quality Improvement Material Forces of Magnetism Involved Organizational Structure Management Style Quality Of Care Autonomy Professional Staff as Teachers Interdisciplinary Relationships

Confidential: Quality Improvement Material Solutions Implemented Based on CHEST guidelines, the clinic worked in conjunction with the Orthopedic Surgery department to raise the INR level for post-surgical orthopedic patients from 1.5 – 2.0 to 2.0 – 2.5. Nursing and pharmacy staff then monitored the patients, adjusting their anticoagulant doses to attain therapeutic levels.

Confidential: Quality Improvement Material Results

Confidential: Quality Improvement Material Results Pre-Intervention Adjusted Hemorrhage Risk 11/06 – 09/07 = 10 in 1000 Post-Intervention Adjusted Hemorrhage Risk 10/07 – 11/08 = 14 in 1000

Confidential: Quality Improvement Material Results

Confidential: Quality Improvement Material Analysis The average patient INR was raised from 1.9 to 2.2 during this 24 month period. Clotting events were reduced from 8 before the intervention to 2 afterwards, decreasing by a factor of 13 after accounting for patient population growth (See chart 1). As clotting dropped, hemorrhaging remained stable, rising only slightly from 10 in 1000 to 14 in 1000 (See chart 3). This intervention was implemented at a time of rapid growth in the clinic’s post-surgical orthopedic patient population, with average monthly numbers rising from 27 to 57 patients per month (See chart 2). These results were statistically significant, achieving significance at the.001 level using a chi-square test for independence. It is estimated that this intervention has prevented $144,000 in health care costs during the 13 months after its inception (assuming a cost of $6,000 per VTE). 1 1 Hawkins, David. “Economic considerations in the prevention and treatment of venous thromboembolism.”American Journal of Health-System Pharmacists 61(2004): S18.

Confidential: Quality Improvement Material Next Steps Data are available for further studies should these be warranted. A growing body of literature supports a minimum INR range of 2.0 – 3.0 for post-surgical orthopedic prophylaxis. Future consideration may be given to further adjustments of the INR, at which time we may conduct another study.